The SAAWP reports on Aplastic Anaemia (AA) and other rare acquired and inherited bone marrow failure disorders.
The SAAWP provides essential data on outcomes after treatment from large numbers of patients that can only be obtained from large registries like the EBMT. It also provides important clinical information needed to help classify and characterise the disease and data on the natural history of the disease and late effects that occur after treatment.
The SAAWP holds the Aplastic Anaemia (AA) database that is the only “disease-specific” database within the EBMT. Data are collected not only on patients receiving transplants but also other forms of therapy, including immunosuppressive therapy.
SAAWP Publications List
Guidelines, Consensus Statements, and Position Papers
The results of the EBMT phase III RACE trial was published today by the New England Journal of Medicine.
The EBMT announced the results of the phase III RACE trial during EBMTs virtual 46th Annual Meeting.